Conference Presentation Confirms Mutual Benefits of Malvern Instruments Open InnovationStrategy
A presentation by technology specialist Dr Richard Tweedie, given as part of the recent UK Formulation Showcase at NanoFormulation 2013 (18–21 June 2013, University of Manchester, UK), illustrated the mutual benefits of an ‘open innovation’ approach to product development. His talk focused on the ‘open innovation’ pathway adopted by Malvern Instruments in collaboration with The University of Leeds in the UK to develop the Aero S, one of the key sample dispersion systems for Malvern’s Mastersizer 3000 laser diffraction particle size analyser.
The Aero S dry powder disperser was launched alongside the Mastersizer 3000 in September 2011 and immediately delivered new capabilities to laser diffraction users, extending dry powder dispersion to even the most fragile materials. The open sharing of information and expertise between Malvern Instruments and The University of Leeds accelerated the system’s development by bringing together academic and commercial understanding, know-how and engineering expertise. Not only did this ‘open innovation’ and collaborative working result in the delivery of a truly innovative product designed to solve real-world challenges, it offers a shining example of successful technology transfer that has benefitted all parties involved: Malvern went to market with a new product, the university team was able to publish results and increase academic understanding in a key are of interest, and the experience gained by the PhD student involved supported his rapid move into commercial employment.
Laser Diffraction systems, such as Malvern’s Mastersizer 3000, determine particle size distributions by measuring the intensity of scattered light as a laser beam passes through a dispersed particulate sample. Effective and appropriate sample dispersion is the key to reliable particle size measurement. However, powder dispersion is a complex phenomenon, governed by a number of competing mechanisms. The Aero S was designed with reference to the most up to date dry powder dispersion theory and introduces a modular dispersion venturi system that allows the user to easily select the most appropriate dispersion mechanism for their samples.
“Redeveloping products when you are the industry leader can be challenging,” said Dr Tweedie. “Open innovation enabled the introduction of fresh viewpoints and new ideas, moving the whole technology to a new level. While the Aero S is the tangible result of this process, the intangible benefits came from the strong relationships formed between Malvern Instruments and The University of Leeds and, more importantly, the new science that it has stimulated”.
For more information the Mastersizer 3000 laser diffraction particle size analyzer and full range of sample dispersion systems please visit http://www.malvern.com/MS3000
Related News
-
News A Day in the Life of a Pharma Event Director
The Day in the Life of series has covered most of the pharmaceutical supply chain looking through the eyes of the people working in the different fields, from R&D to manufacturing. What we haven't seen yet, is the role that non-pharma companies can... -
News On Track at CPHI Milan: The RTU Alliance on the importance of packaging innovation
As CPHI Milan gets ever closer, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma, and the innovations that are set to shake up the industry. -
News CPHI Milan Speaker Spotlight: The microbiome and investing in future therapies
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conference. -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News Latest updates for semaglutide: reduction of renal failure risk
Recent data presented at the 2024 European Society for Cardiology (ESC) conference analysed Novo Nordisk’s Ozempic (semaglutide) and its effectiveness in the management of chronic kidney disease (CKD). This follows previous analysis on semaglutid... -
News CPHI Milan Speaker Spotlight: CDMO relations with Pharma and Start-Ups
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News What can you expect from CPHI Milan 2024?
CPHI Milan 2024 marks the 35th anniversary of CPHI. The 35th Edition of the show, taking place 8–10 October, promises to be a celebration of everything pharma, covering every sector, and featuring thought leaders and trailblazers shaking up the i...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance